Piramal Pharma Limited — Important, 10-08-2026: Updates
10-08-2026 | 06:09 pm
10-08-2026 | 06:09 pm
Piramal Pharma approved acquiring an additional 41% stake in Yapan Bio, a CDMO for vaccines and biologics. This increases PPL's holding to ~74%, making Yapan Bio a subsidiary and strengthening PPL's CDMO capabilities.
No comments yet. Be the first to comment!
